Japanese Journal of Urology最新文献

筛选
英文 中文
[IPSILATERAL SYNCHRONOUS MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA AND CLEAR CELL PAPILLARY RENAL CELL CARCINOMA: A CASE REPORT AND REVIEW OF THE LITERATURE]. [同侧同步性粘液管状和梭形细胞癌及透明细胞乳头状肾细胞癌:1例报告及文献复习]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.134
Mio Tanigawa, Toru Huruuchi, Koetsu Tamura, Fumio Nakajima, Hideharu Domoto, Kiyoshi Mukai, Yoji Nagashima
{"title":"[IPSILATERAL SYNCHRONOUS MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA AND CLEAR CELL PAPILLARY RENAL CELL CARCINOMA: A CASE REPORT AND REVIEW OF THE LITERATURE].","authors":"Mio Tanigawa,&nbsp;Toru Huruuchi,&nbsp;Koetsu Tamura,&nbsp;Fumio Nakajima,&nbsp;Hideharu Domoto,&nbsp;Kiyoshi Mukai,&nbsp;Yoji Nagashima","doi":"10.5980/jpnjurol.111.134","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.134","url":null,"abstract":"<p><p>Renal cell carcinoma (RCC), the most common solid lesion of the kidney, accounts for approximately 2%-3% of all malignancies among adults. Clear cell carcinoma and papillary cell carcinoma are the most common types of renal tumors. Some case reports have described synchronous benign and malignant tumors in the same kidney. In particular, angiomyolipoma and RCC in patients with tuberous sclerosis (TSC) and non-TSC have been reported many times in the literature. However, unilateral concordance of malignant renal tumors is very rare; thus, only few cases have been reported in the literature.Here we report the case of a 58-year-old male who had ipsilateral synchronous mucinous tubular and spindle cell carcinoma (MTSCC) and clear cell papillary renal cell carcinoma (CCPRCC). Both cancers are rare and relatively recently defined subtypes of RCC. Additionally, both were successfully treated using partial nephrectomy. MTSCC has been a distinct entity in the World Health Organization classification of kidney tumors since 2004. The classic type of MTSCC is characterized by small elongated tubules lined with clear cuboidal or spindle cells with mucinous stroma. Neoplastic cells always exhibit low-grade histological features. However, unclassified variants of MTSCC, such as mucin-poor, papillary, high-grade, and sarcomatoid variants, have also been reported. MTSCC is considered to have a relatively good prognosis, but some patients with poor prognoses have recently been reported. CCPRCC is a recently recognized entity and represents the fourth most common variant of RCC. It has unique morphological and immunohistochemical features and shows indolent clinical behavior. Microscopically, CCPRCC may mimic other RCCs with clear cell features, such as clear cell RCC, translocation RCC, and papillary RCC, with clear cell changes. In 2006, CCPRCC was described as a subtype of renal tumors in patients with end-stage renal disease. However, currently, CCPRCC has also been shown to occur in kidneys with normal function.To the best of our knowledge, this is the first report of ipsilateral synchronous MTSCC and CCPRCC, which we present with a review of the pertinent literature.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"134-139"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39537537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A CASE OF COMPLETE RESECTION OF PROGRESSIVE RETROPERITONEAL LEIOMYOSARCOMA WITH INFERIOR VENA CAVA TUMOR THROMBUS AND LIVER METASTASIS]. 【进行性腹膜后平滑肌肉瘤伴下腔静脉肿瘤血栓及肝转移全切除1例】。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.145
Yuma Kujime, Atsunari Kawashima, Nobuhiko Kawata, Kentaro Takezawa, Taigo Kato, Koji Hatano, Takeshi Ujike, Toyofumi Abe, Shinichiro Fukuhara, Kazutoshi Fujita, Motohide Uemura, Hiroshi Kiuchi, Ryoichi Imamura, Norio Nonomura
{"title":"[A CASE OF COMPLETE RESECTION OF PROGRESSIVE RETROPERITONEAL LEIOMYOSARCOMA WITH INFERIOR VENA CAVA TUMOR THROMBUS AND LIVER METASTASIS].","authors":"Yuma Kujime,&nbsp;Atsunari Kawashima,&nbsp;Nobuhiko Kawata,&nbsp;Kentaro Takezawa,&nbsp;Taigo Kato,&nbsp;Koji Hatano,&nbsp;Takeshi Ujike,&nbsp;Toyofumi Abe,&nbsp;Shinichiro Fukuhara,&nbsp;Kazutoshi Fujita,&nbsp;Motohide Uemura,&nbsp;Hiroshi Kiuchi,&nbsp;Ryoichi Imamura,&nbsp;Norio Nonomura","doi":"10.5980/jpnjurol.111.145","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.145","url":null,"abstract":"<p><p>We present a case in a 74-year-old female patient whose initial symptom was right flank pain. Enhanced computed tomography showed a mass (about 15×12 cm) in the retroperitoneum, inferior vena cava tumor thrombus (Level III: Neves and Zincke system) and liver metastasis. The primary tumor exploded and inferior vena cava tumor thrombus caused congestive liver one and a half month later. Preoperative diagnosis was right adrenocortical carcinoma (cT4N0M1 stage IV). We performed complete resection of tumor including metastasis. Pathological findings on the resected specimen revealed pleomorphic leiomyosarcoma, which was discontinuous tumor from the right normal adrenal grand. There was no evidence of local recurrence or metastasis after 6 months with no additional treatment.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"145-149"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39537539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[IMPACT OF MEMBRANOUS URETHRAL LENGTH IN DE NOVO STRESS URINARY INCONTINENCE FOLLOWING HOLMIUM LASER ENUCLEATION OF THE PROSTATE]. [膜性尿道长度对钬激光前列腺摘除术后新发应激性尿失禁的影响]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.68
Shuichiro Kobayashi, Madoka Urushido, Takashi Tamiya, Masataka Yano, Satoshi Kitahara
{"title":"[IMPACT OF MEMBRANOUS URETHRAL LENGTH IN DE NOVO STRESS URINARY INCONTINENCE FOLLOWING HOLMIUM LASER ENUCLEATION OF THE PROSTATE].","authors":"Shuichiro Kobayashi,&nbsp;Madoka Urushido,&nbsp;Takashi Tamiya,&nbsp;Masataka Yano,&nbsp;Satoshi Kitahara","doi":"10.5980/jpnjurol.111.68","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.68","url":null,"abstract":"<p><p>(Purpose) Holmium laser enucleation of the prostate (HoLEP) is widely performed in recent years; however, difficulties of surgical techniques and high frequency of postoperative stress urinary incontinence (SUI) remain as significant problems. We determined the predictive factors for de novo SUI after HoLEP. (Patients and methods) A total of 303 patients with benign prostatic hyperplasia who underwent HoLEP were retrospectively evaluated between July 2013 and April 2019. Of these, 109 patients underwent MRI preoperatively. Patients who were unable to answer the questionnaire regarding their SUI because of dementia, those who presented with SUI preoperatively, and those with placed Foley catheter at the time of MRI were excluded. Hence, a total of 83 patients were eligible for the present study. We recorded the MRI findings and clinical variables, including membranous urethral length (MUL), transitional zone (TZ) volume, serum prostate-specific antigen levels, operative time, and presence or absence of SUI. The predictive factors for de novo SUI were determined using multivariable logistic regression analysis. (Results)De novo SUI occurred in 19 (22.9%) patients but disappeared in 16 (84.2%) patients at a mean duration of 14 weeks. The mean MUL was 17.2 mm. Univariate analysis showed that MRI TZ volume >40 mL, MUL ≤17 mm, operative time >100 min, and enucleation time >50 min were associated with de novo SUI. In multivariable logistic regression analysis, MUL ≤17 mm (odds ratio [OR], 23.81; 95% confidence interval [CI], 4.34-447.19; P < 0.0001) and operative time >100 min (OR, 3.91; 95% CI, 1.20-14.01; P = 0.023) were significantly associated with de novo SUI. (Conclusions) Although de novo SUI occurred occasionally after HoLEP, most of them improved in about 3 months. The MRI measurement of MUL was shown to be a practical tool for predicting de novo SUI after HoLEP.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 3","pages":"68-73"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39220283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PATIENT-REPORTED OUTCOME AFTER ILEAL NEOBLADDER]. [患者报告的回肠新膀胱术后结果]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.107
Ryotaro Tomida, Ousuke Arai, Shunsuke Iuchi, Masafumi Matsumura, Katsuyoshi Hashine
{"title":"[PATIENT-REPORTED OUTCOME AFTER ILEAL NEOBLADDER].","authors":"Ryotaro Tomida,&nbsp;Ousuke Arai,&nbsp;Shunsuke Iuchi,&nbsp;Masafumi Matsumura,&nbsp;Katsuyoshi Hashine","doi":"10.5980/jpnjurol.111.107","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.107","url":null,"abstract":"<p><p>(Objectives) Investigation of patient-reported outcome (PRO) after ileal neobladder for bladder cancer. (Patients and methods) Forty patients who underwent radical cystectomy and ileal neobladder between July 2007 and December 2017 were asked to complete a questionnaire. PRO was evaluated using the Medical Outcomes Study Short Form-8 (SF-8) for general health-related quality of life (QOL) and the Bladder Cancer Index and the Japanese version of the Functional Assessment of Cancer Therapy-Bladder for disease specific QOL. Patients were divided into two groups according to the postoperative period (early and late), and the differences in questionnaire results between the groups were evaluated. (Results) All scores on the SF-8 were over 50 points, exceeding the Japanese national standard of 50 points for all items. The physical and mental summary scores were also favorable. For disease-specific QOL, only daytime incontinence was significantly higher in the late group, with daytime incontinence two or more times per week at 42.1%, compared to 20.0% in the early group (P=0.0403). A comparison of daytime urinary incontinence in four groups during the postoperative period showed that urinary incontinence was least frequent among patients between 64 and 101 months after surgery; patients in this group were also the youngest in age at the time of surgery. (Conclusions) Cross-sectional analysis of PRO revealed that patients with ileal neobladder had good general health-related QOL after surgery, but urinary incontinence was a significant problem.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"107-113"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39534651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[EXAMINATION OF THE INCIDENCE AND RISK FACTORS ABOUT URINARY CANCERS (RENAL, BLADDER, AND PROSTATE) IN EXAMINEES OF HEALTH SCREENING]. [健康筛查对象泌尿系癌(肾癌、膀胱癌、前列腺癌)发病率及危险因素的调查]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.114
Syunsuke Nobata, Syoutarou Kiuchi, Megumi Watanabe, Atsuyoshi Mori, Sigeki Mutou, Hideaki Miyake
{"title":"[EXAMINATION OF THE INCIDENCE AND RISK FACTORS ABOUT URINARY CANCERS (RENAL, BLADDER, AND PROSTATE) IN EXAMINEES OF HEALTH SCREENING].","authors":"Syunsuke Nobata,&nbsp;Syoutarou Kiuchi,&nbsp;Megumi Watanabe,&nbsp;Atsuyoshi Mori,&nbsp;Sigeki Mutou,&nbsp;Hideaki Miyake","doi":"10.5980/jpnjurol.111.114","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.114","url":null,"abstract":"<p><p>(Objective) We studies morbidity and risk factors related to urinary cancers (renal, bladder, and prostate) from health screening interviews and results. (Subjects and Methods) We extracted data from 48,454 adults who underwent health screenings between April 2006 and March 2008.Of particular interest were examinees who were newly diagnosed with urinary cancer after the consultation. The data examined included factors such as sex, age, total years of smoking, body mass index (BMI), drinking status, weight gain (>10 kg from the age of 20), accumulation of stress, sleep condition/habits, adequate dairy product intake, hypertension, diabetes mellitus, and dyslipidemia. (Results) The numbers of patients who were diagnosed with renal, bladder, or prostatic cancer were 45, 47, and 215, respectively. The corresponding morbidity rates were 0.093%, 0.097%, and 0.721%. From the results of the univariate analysis, renal cancer was found to be significantly correlated with the male gender, old age, high BMI, drinking, weight gain, and hypertension. In addition, we found a significant correlation between bladder cancer and male gender, old age, total years of smoking, and drinking. Prostate cancer was significantly correlated with old age, total years of smoking, weight gain, accumulation of stress, and dyslipidemia. The multivariate analysis demonstrated a significant correlation between renal cancer and old age, between bladder cancer and both male gender and old age, and between prostatic cancer and both old age and dyslipidemia. (Conclusion) Old age was identified as a common risk factor that is significantly and independently correlated with urinary cancers.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"114-119"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39534652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[LOCAL REACTIONS OF LUTEINIZING HORMONE-RELEASING HORMONE AGENTS AND ITS EFFECTS ON CLINICAL OUTCOMES IN PROSTATE CANCER PATIENTS]. [促黄体激素释放激素药物在前列腺癌患者中的局部反应及其对临床预后的影响]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.120
Tomoyuki Shimabukuro, Chietaka Ohmi, Ryoko Nagamitsu, Koji Shiraishi, Hideyasu Matsuyama
{"title":"[LOCAL REACTIONS OF LUTEINIZING HORMONE-RELEASING HORMONE AGENTS AND ITS EFFECTS ON CLINICAL OUTCOMES IN PROSTATE CANCER PATIENTS].","authors":"Tomoyuki Shimabukuro,&nbsp;Chietaka Ohmi,&nbsp;Ryoko Nagamitsu,&nbsp;Koji Shiraishi,&nbsp;Hideyasu Matsuyama","doi":"10.5980/jpnjurol.111.120","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.120","url":null,"abstract":"<p><p>(Background) Currently, luteinizing hormone-releasing hormone (LH-RH) agonists and antagonists are used for androgen-deprivation therapy (ADT). However, they are associated with subcutaneous granuloma, rubor, dolor, calor, and eventual ulcer and/or abscess formation. The prevalence of these adverse effects, causes and mechanisms, and effects on serum testosterone levels and clinical outcomes are poorly understood. (Method) We collected the clinical records of men with pathologically diagnosed prostate cancer who were followed in our hospital. The primary aim of the study was to determine the prevalence of granuloma formation, its causes, and the mechanisms involved. The secondary aim was to analyze the effects of subcutaneous induration on serum testosterone levels and clinical outcomes. (Results) Overall, 185 men using leuprorelin (n=161; median age, 75 years), degarelix (n=21; median age, 76), or goserelin (n=3; median age, 76) were analyzed. In the leuprorelin cohort, 51 patients (33.5%) had subjective and/or objective subcutaneous induration and 2 (1.2%) had a large lesion (diameter > 3.0 cm). In the degarelix cohort, 18 patients (85.7%) developed induration and 8 (38%) had a large lesion. One month after the start of ADT, patients in the leuprorelin and degarelix cohorts had median serum testosterone levels that reached the same level as that after castration. There was no significant difference in the overall survival rate between the leuprorelin and degarelix cohorts. There was no significant difference in the serum testosterone level or overall survival rate between patients with or without induration. (Conclusions) The local adverse effects of LH-RH agents are prevalent, but we can regulate the adverse effects by understanding the mechanism involved. The formation of subcutaneous induration did not affect the serum testosterone level or clinical outcome.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"120-129"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39537535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A CASE OF MUCIN-PRODUCING UROTHELIAL-TYPE ADENOCARCINOMA OF THE PROSTATE (MPUAP) WITH LONG-TERM SURVIVAL AFTER TOTAL CYSTECTOMY]. [1例产粘蛋白尿路上皮型前列腺腺癌(mpuap),全膀胱切除术后长期存活]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.154
Yusuke Fukiage, Takafumi Kabuto, Ryusei Yokokawa, Manabu Kurosawa
{"title":"[A CASE OF MUCIN-PRODUCING UROTHELIAL-TYPE ADENOCARCINOMA OF THE PROSTATE (MPUAP) WITH LONG-TERM SURVIVAL AFTER TOTAL CYSTECTOMY].","authors":"Yusuke Fukiage,&nbsp;Takafumi Kabuto,&nbsp;Ryusei Yokokawa,&nbsp;Manabu Kurosawa","doi":"10.5980/jpnjurol.111.154","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.154","url":null,"abstract":"<p><p>Mucin-producing urothelial-type adenocarcinoma of the prostate (MPUAP) is a very rare disease. MPUAP has been reported to progress faster than the rate at which normal prostate cancer progresses. We report a case of MPUAP with long-term survival. The patient was a 65-year-old man. Computed tomography and magnetic resonance imaging showed a cystic lesion extending from the prostate to the urethra. We performed transrectal prostate biopsy and transurethral resection of the tumor, and the pathological diagnosis was adenocarcinoma. Subsequently, we performed total cystectomy, ureterostomy, and pelvic lymphadenectomy. Based on the pathological and immunostaining findings (prostate-specific antigen negativity, CDX-2 positivity, cytokeratin 20 positivity, 34β-E12 positivity), the patient was diagnosed with MPUAP. Four years after the surgery, recurrence or metastasis was not observed.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"154-158"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39537541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[TWO CASES OF FALSE POSITIVE 123I-MIBG SCINTIGRAPHY FINDINGS OF UPTAKE IN ADRENAL TUMORS]. [肾上腺肿瘤中摄取123i-mibg显像假阳性2例]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.159
Shota Fukae, Yuki Horibe, Yohei Yamanaka, Tetsuji Soda, Sachiko Hongo, Iwao Yoshioka, Shingo Takada
{"title":"[TWO CASES OF FALSE POSITIVE <sup>123</sup>I-MIBG SCINTIGRAPHY FINDINGS OF UPTAKE IN ADRENAL TUMORS].","authors":"Shota Fukae,&nbsp;Yuki Horibe,&nbsp;Yohei Yamanaka,&nbsp;Tetsuji Soda,&nbsp;Sachiko Hongo,&nbsp;Iwao Yoshioka,&nbsp;Shingo Takada","doi":"10.5980/jpnjurol.111.159","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.159","url":null,"abstract":"<p><p>Case 1 was a 71-year-old female who had been examined by her primary care physician for palpitation and hypertension. Urinary hormone test results revealed elevated urine metanephrine at 0.20 mg/day, urine normetanephrine at 0.45 mg/day and urine noradrenalin at 234.9 μg/day. <sup>123</sup>I-MIBG scintigraphy showed uptake in the right suprarenal area, thus she was referred to our department because of pheochromocytoma. She underwent a laparoscopic right adrenalectomy and pathological results led to a diagnosis of adrenocortical adenoma. Case 2 was a 70-year-old female who had been examined at our hospital for hypertension. Blood hormone test results revealed elevated noradrenalin at 0.70 ng/ml. <sup>123</sup>I-MIBG scintigraphy showed uptake in the left suprarenal area and she was referred to our department because of pheochromocytoma. She underwent a laparoscopic left adrenalectomy, thus pathological results showed no tumor lesion.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 4","pages":"159-163"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39537542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A CASE OF SPLENOGONADAL FUSION PRESENTING NON-PALPABLE TESTIS AND PROXIMAL HYPOSPADIAS]. [1例脾性腺融合表现为不可触及的睾丸和近端尿道下裂]。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.44
Akinaru Yamamoto, Satoko Matsuyama, Futoshi Matsui, Koji Yazawa, Fumi Matsumoto
{"title":"[A CASE OF SPLENOGONADAL FUSION PRESENTING NON-PALPABLE TESTIS AND PROXIMAL HYPOSPADIAS].","authors":"Akinaru Yamamoto,&nbsp;Satoko Matsuyama,&nbsp;Futoshi Matsui,&nbsp;Koji Yazawa,&nbsp;Fumi Matsumoto","doi":"10.5980/jpnjurol.111.44","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.44","url":null,"abstract":"<p><p>A 9-month-old boy, having a history of cardiac surgery in neonatal period, was referred to our department for evaluation of genital anomalies. The antenatal course was uneventful, except for unknown gender. His family history was unremarkable. He was delivered at full term, and his birth weight was 3,510 g. Physical examination revealed proximal hypospadias and a non-palpable testis on the left side. Chromosome studies showed a normal male karyotype with positive SRY. At the age of 14 months, he underwent hypospadias repair. Three months later, left testicular exploration was performed along with orchidopexy of an ascending testis on the contralateral side. As nothing was found through an inguinal incision on the left side, laparoscopy was indicated. Laparoscopic observation revealed a small dark reddish mass cranially connected to the left hypoplastic testis that was located high in the left iliac fossa. The epididymis and vas deference looked abnormal, and detachment to the testis was apparent. Testicular vessels were undifferentiated from the mass. Therefore, the left testis was excised with the mass. Histopathological examination confirmed the testis and spleen tissue, and the diagnosis of splenogonadal fusion was made postoperatively.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 2","pages":"44-47"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38902968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[COMBINING MODALITY THERAPY WITH SURGERY CAN PROVIDE LONG-TERM SURVIVAL WITH IMPROVED QUALITY OF LIFE FOR PATIENTS WHO HAVE PROSTATE CANCER WITH INTRACRANIAL DURAL METASTASIS: A CASE REPORT]. 前列腺癌合并颅内硬脑膜转移的患者联合手术治疗可提高患者的长期生存率和生活质量:1例报告。
Japanese Journal of Urology Pub Date : 2020-01-01 DOI: 10.5980/jpnjurol.111.98
Chikao Aoyagi, Hiroshi Matsuzaki, Naoaki Sakata, Yu Okabe, Ryusaburo Furuya, Shinichiro Irie, Nobuyuki Nakamura, Hirofumi Matsuoka, Masani Nonaka, Toru Inoue, Masatoshi Tanaka
{"title":"[COMBINING MODALITY THERAPY WITH SURGERY CAN PROVIDE LONG-TERM SURVIVAL WITH IMPROVED QUALITY OF LIFE FOR PATIENTS WHO HAVE PROSTATE CANCER WITH INTRACRANIAL DURAL METASTASIS: A CASE REPORT].","authors":"Chikao Aoyagi,&nbsp;Hiroshi Matsuzaki,&nbsp;Naoaki Sakata,&nbsp;Yu Okabe,&nbsp;Ryusaburo Furuya,&nbsp;Shinichiro Irie,&nbsp;Nobuyuki Nakamura,&nbsp;Hirofumi Matsuoka,&nbsp;Masani Nonaka,&nbsp;Toru Inoue,&nbsp;Masatoshi Tanaka","doi":"10.5980/jpnjurol.111.98","DOIUrl":"https://doi.org/10.5980/jpnjurol.111.98","url":null,"abstract":"<p><p>A 61-year-old man visited our hospital with a headache and left visual field defect. A head MRI showed an intracranial dural tumor with cerebral compression, which was suspected to be metastatic. Analysis of the tumor markers revealed an increase in prostate-specific antigen (PSA) levels (172.8 ng/mL), and therefore prostate cancer was suspected as the primary tumor. Histological diagnosis of a prostatic tissue sample using a transrectal needle biopsy gave a prostate carcinoma with Gleason score of 5+4=9. Additional imaging examinations revealed metastatic lesions in the intra-pelvic lymph node and bones. These data indicated to us that curative surgery was unlikely to be successful, but finally we decided to perform a craniotomy for tumor resection for the intracranial dural tumor to remove his neurological symptoms. After surgery, his headache and visual field defect improved. The pathological finding was intracranial dural metastasis from prostate cancer and the clinical stage was diagnosed as T3bN1M1c in the UICC criteria (ver. 8). Endocrine therapy with degarelix and bicalutamide was started for the primary and residual metastatic prostate cancers. After one year of initial treatment, bicalutamide was changed to enzalutamide because of a tendency towards increased plasma PSA levels. The patient has survived for two and a half years after surgery with no new metastatic tumors or intracranial tumors. Our experience indicates that combined modality therapy with surgery can provide long-term survival with no cranial nerve disorders for patients who have prostate cancer with intracranial dural metastasis.</p>","PeriodicalId":38850,"journal":{"name":"Japanese Journal of Urology","volume":"111 3","pages":"98-101"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39218629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信